It was demonstrated that the Col I, Col III and TGF-1 protein expression levels, and the CVF, were higher in the rats with MI compared with those who underwent the sham operation (Fig
The primary endpoint was a composite of death from cardiovascular causes, non-fatal MI or non-fatal stroke, with a significant 20% reduction in the semaglutide group versus placebo
A 2022 commentary in Wound Repair and Regeneration stated: "Fewer than 15% of compounds showing efficacy in rodent wound models achieve statistical significance in Phase III human wound trials" [8]
Meanwhile, Swiss multinational Roches clinical candidates include its once-daily weight loss pill that has shown promise in early-stage studies
Future trials with larger sample sizes will be needed to determine whether semaglutide alone or in combination with other liver-targeted agents will improves outcomes such as liver-related morbidity and mortality in patients with NASH and compensated cirrhosis, Loomba said